Bank of America just raised its EUR/USD forecast
Cathie Wood’s ARK ETFs have reported their daily trades for Tuesday, August 19th, 2025, with significant activity across a range of stocks. Leading the purchases was Robinhood Markets Inc (NASDAQ:HOOD), with ARK investing a substantial $17,357,438 through its ARKK ETF. This move suggests a growing confidence in the brokerage platform, which has been a recurring interest for ARK over recent days.
In the field of biotechnology, ARK’s ARKK and ARKG ETFs continued to add shares of CRISPR Therapeutics AG (NASDAQ:CRSP) and BEAM Therapeutics Inc (NASDAQ:BEAM), spending $12,888,814 and $9,237,898 respectively. These trades reinforce ARK’s bullish stance on gene-editing technologies, a sector that has been a consistent feature in their investment strategy.
ARK also showed a keen interest in GenDx Holdings Corp (NASDAQ:WGS), acquiring shares worth $15,905,702. This purchase aligns with ARK’s pattern of investing in innovative health care solutions, as seen in previous trading sessions.
In a notable sale, ARK parted ways with 218,031 shares of Genius Sports Ltd (NYSE:GENI) from its ARKW ETF, totaling $2,819,140. This divestment could signal a shift in ARK’s sentiment towards the sports data company, which has faced competitive and regulatory challenges.
Other significant trades included buying 346,695 shares of Twist Bioscience Corp (NASDAQ:TWST) and 468,042 shares of 10X Genomics Inc (NASDAQ:TXG), amounting to $9,714,393 and $6,299,845 respectively. These investments underscore ARK’s commitment to companies at the forefront of scientific research and development.
Additional acquisitions were made in Pacific Biosciences of California Inc (NASDAQ:PACB), PagerDuty Inc (NYSE:PD), and L3Harris Technologies Inc (NYSE:LHX), with ARK clearly favoring innovative companies across diverse sectors.
The report also highlighted a sell-off of Tempus Ai Inc (NYSE:TEM) shares worth $8,939,534, a move that might reflect ARK’s strategy to rebalance its portfolio in response to market dynamics or company performance.
By covering the full spectrum of ARK’s daily trades, investors gain insight into the strategic shifts and focal points of Cathie Wood’s ETFs, which continue to emphasize disruptive innovation and growth potential in various sectors.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.